Loading…
Loading…
PKPH (Peak Pharmaceuticals, Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
PKPH does not currently pay a dividend.
See exactly how PKPH's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for PKPH and 80,000+ other tickers.
Peak Pharmaceuticals, Inc., an American bio-pharmaceutical and nutraceutical company, specializes in the development, manufacturing, marketing, and sale of therapeutic products derived from hemp extracts. The firm particularly concentrates on formulating over-the-counter, THC-free, hemp-based remedies for human application, designed to help prevent and mitigate symptoms linked to inflammatory and auto-immune conditions. Originally established in 2007 as Cannabis Therapy Corporation, the company rebranded to Peak Pharmaceuticals, Inc. in December 2014 and maintains its main office in Scottsdale, Arizona.
